Cancer Health Treatment Update The Young Ambassador for Women With Lung Cancer Diagnosed with Stage IV lung cancer at age 33, Sydney Barned, MD, is on a mission to get this disease the attention it deserves, including among young women. First Cancer TIL Therapy Gets FDA Approval for Advanced Melanoma Amtagvi (lifileucel) is the first treatment for cancer that uses immune cells called tumor-infiltrating lymphocytes, or TILs. Outcomes After Stem Cell Transplant Have Improved for Elderly Patients With Acute Myeloid Leukemia Historically, many patients over age 65 have been considered too infirm to receive intensive chemotherapy or stem cell transplants. Cancer Health Spring 2024 Check out our latest print edition! Advertisement GoFundMe Has Become a Health Care Utility GoFundMe and similar fundraising platforms tend to perpetuate socioeconomic disparities that already affect medical bills and debt.  FDA Authorizes New COVID-19 Prevention for Immunocompromised People Pemgarda (pemivibart) is a monoclonal antibody that helps protect people who may not respond well to COVID vaccines. More News About COVID-19 See all our coverage of COVID-19, including how it affects people living with cancer. For more news about SARS-CoV-2, visit our sister site, COVIDHealth.com. Newsfeed $25M Grant to Morehouse Researchers Addressing Cancer Disparities Kate Middleton, Princess of Wales, Reveals She Has Cancer [VIDEO] Congress Considers FY24 Funding Bill That Prioritizes Cancer Programs Amid Difficult Budget Cycle What’s Driving Early Onset Colon Cancer? A Study Pinpoints Two Factors. Blog: National Cancer Institute First Cancer TIL Therapy Gets FDA Approval for Advanced Melanoma Lutathera Shows Promise for Some Neuroendocrine Tumors Blood Test May Guide Who Needs Chemo After Colorectal Cancer Surgery Pump Up the Volume: “Priming Agents” May Improve Cancer Liquid Biopsies Newsfeed $25M Grant to Morehouse Researchers Addressing Cancer Disparities Kate Middleton, Princess of Wales, Reveals She Has Cancer [VIDEO] Congress Considers FY24 Funding Bill That Prioritizes Cancer Programs Amid Difficult Budget Cycle What’s Driving Early Onset Colon Cancer? A Study Pinpoints Two Factors. Blog: National Cancer Institute First Cancer TIL Therapy Gets FDA Approval for Advanced Melanoma Lutathera Shows Promise for Some Neuroendocrine Tumors Blood Test May Guide Who Needs Chemo After Colorectal Cancer Surgery Pump Up the Volume: “Priming Agents” May Improve Cancer Liquid Biopsies

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: